CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


C3+ Holter MonitorWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (8)


Name (Synonyms) Correlation
drug1176 Generalized Anxiety Disorder-7 (GAD 7) Wiki 1.00
drug2198 Post Traumatic Stress Disorder questionnaire (PTSD-8) Wiki 1.00
drug2064 Patient Health Questionnaire (PHQ-9) Wiki 1.00
drug732 Confinement and Communication During the COVID-19 Pandemic Wiki 1.00
drug1042 Experiences in Close Relationship Scale questionnaire (ECR-S) Wiki 1.00
drug1725 Mental Health questionnaire Wiki 1.00
drug370 Background questionnaire Wiki 1.00
drug1397 Impact of COVID-19 questionnaire Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D040921 Stress Disorders, Traumatic NIH 0.19
D001008 Anxiety Disorders NIH 0.15

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring

The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.

NCT04395664 COVID-19 Device: C3+ Holter Monitor

Primary Outcomes

Measure: In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Measure: Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Secondary Outcomes

Measure: Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Measure: Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months

Measure: Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis

Time: 4 months


No related HPO nodes (Using clinical trials)